The formation of this RNA–protein complex results in enrichment of repressive epigenetic markers at the MMP-14 promoter, decreased binding of YY1, and reduced MMP-14 transcription, thereby inhibiting the tumorigenesis and aggressiveness of gastric cancer. The gene discussed is MMP14; the disease is gastric cancer.